Pfizer Neuroscience & Pain

Ver el organigrama con sus 1 ejecutivos principales

Biografías más buscadas en Pfizer Neuroscience & Pain

• Scot Styren, Executive Director and Group Head, Internal Medicine

Crear su alerta
para seguir los movimientos de los ejecutivos en Pfizer Neuroscience & Pain.

Pfizer Neuroscience & Pain tiene 2.276 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Adaptive Phage Therapeutics (Estados Unidos).

Popular M&A news in Biotecnología

• Histogen has filed for bankruptcy protection  (publicado el 19 de abril de 2024).
• Bruker has announced the acquisition of NanoString Technologies  (publicado el 18 de abril de 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (publicado el 16 de abril de 2024).

Otros contactos sugeridos en el sector Biotecnología

• Vik Bajaj - Director en Interline Therapeutics
• Ali Behbahani - Non-Executive Director en Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board en Sensorion

Saber más sobre el sector Biotecnología >

Últimos comunicados de prensa de Pfizer Neuroscience & Pain

• Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union | Pfizer
• Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences | Pfizer
• Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older | Pfizer
• Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine | Pfizer
• Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate | Pfizer
• Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age | Pfizer
• Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates | Pfizer
• When AI Meets Biology | Pfizer
• Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine | Pfizer
• Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference | Pfizer
• View more press releases Close

Redes sociales sobre Pfizer Neuroscience & Pain

• Pfizer Neuroscience & Pain en Wikipedia, Google News y Yahoo Finance
• Pfizer Neuroscience & Pain en LinkedIn, Twitter y YouTube

Contactar a través de e-mail con sus ejecutivos Scot Styren

Llame a Pfizer Neuroscience & Pain al +1 212...

Ver el organigrama

Register to receive your alert

Señalar un error